Conflict of interests: Dr. Bi, Mr. Sun, and Dr. Gelernter have no disclosures. Dr. Kranzler has been a consultant or advisory board member for Alkermes, Lilly, Lundbeck, Pfizer, and Roche. He is also a member of the American Society of Clinical Psychopharmacology's Alcohol Clinical Trials Initiative, which is supported by Lilly, Lundbeck, Abbott, and Pfizer.
Comparing the utility of homogeneous subtypes of cocaine use and related behaviors with DSM-IV cocaine dependence as traits for genetic association analysis
Version of Record online: 11 DEC 2013
© 2013 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Volume 165, Issue 2, pages 148–156, March 2014
How to Cite
2013. Comparing the Utility of Homogeneous Subtypes of Cocaine Use and Related Behaviors With DSM-IV Cocaine Dependence as Traits for Genetic Association Analysis. Am J Med Genet Part B 165B:148–156., , , .
- Issue online: 6 FEB 2014
- Version of Record online: 11 DEC 2013
- Manuscript Accepted: 20 NOV 2013
- Manuscript Received: 2 MAY 2013
- NIH. Grant Numbers: DA12849, DA12690, AA03510, AA11330, AA13736
- VISN 1 and VISN 4 Mental Illness Research, Education, and Clinical Centers (MIRECCs)
Additional supporting information may be found in the online version of this article at the publisher's web-site.
FIG. SI. Overview of our two-layer cascaded cluster analysis.
TABLE SI. Description of 53 Categorical Input Cocaine-Related Characteristics Used to Generate Cocaine Use Subtypes
TABLE SII. Description of 15 Continuous Input Cocaine-Related Characteristics Used to Generate Cocaine Use Subtypes and How They Were Categorized
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.